biosensis Pty Ltd

Biosensis specializes in antibodies and reagents for Neuroscience. Our neuroscience portfolio includes products for research in neurodegenerative diseases, neurodevelopment,and neuro-metabolism. Areas of focus include Alzheimer's, Parkinson's and ALS diseases, as well as autophagy and metabolic and stress disorders including metabolic syndrome research, obesity, and neuroimmunology and inflammation with particular emphasis on neurotrophins and neurotrophin receptors for which Biosensis has been the worldwide leader and OEM supplier for more than 30 years. Biosensis also offers more than 200 high-quality ELISA kits for a wide range of protein targets. Our assays are validated for a variety of sample matrices and where possible, tested by independent research laboratories. Our ELISA kits are complete, ready-to-use and without the need for additional reagents, buffers or plates.

Our new range of RapidTM ELISA assays can be performed in less than 4 hours without compromising on accuracy, specificity and sensitivity. These assays target potential biomarkers, such as oligomeric Aβ peptides (Alzheimer's Disease, AD), mature BDNF (psychiatric disorders), proNGF (cancer) and p75NTR/NGFR (Amytrophic Lateral Sclerosis, ALS). Why purchase from Biosensis? Biosensis is a company formed by a team of life scientists and business people dedicated to the support of researchers in academia and industry worldwide. The team has a combined total of over 50 years experience in the commercialization of life science reagents for the life science research and diagnostic markets. We are therefore able to offer a level of customer support and expertise unmatched in the neuroscience reagent industry.